Table CS1: Consistent series of drug-related deaths - 'extra' deaths and which of the drugs that were present for each of the 'extra' deaths meant that they were counted in the consistent series: 2000 to 2014
200020012002200320042005200620072008200920102011201220132014
Footnotes:
  1. Broadly speaking, counting deaths on the basis of the classification of the drugs at the end of the latest year which is covered by the publication. refer to Annex F for the full definition.
  2. Broadly speaking, counting deaths on the basis of the classification of the drugs at the time of death. refer to Annex A for the full definition.
  3. For example, deaths which are counted in the consistent series but are not counted in the standard definition.
  4. Mephedrone has been a controlled substance with effect from 16 April 2010, so subsequent deaths involving it are counted in the 'standard definition' figures (and not 'extra' deaths).
  5. Phenazepam has been a controlled substance with effect from 13 June 2012, so subsequent deaths involving it are counted in the 'standard definition' figures (and not 'extra' deaths).
  6. Tramadol and zopiclone have been controlled substances with effect from 10 June 2014, so subsequent deaths involving either (or both) of them are counted in the 'standard definition' figures (and not 'extra' deaths).
  7. For example, one or more of APB, API and BZP were present.
Drug-related deaths: consistent series1293339388330365346430474590570512606604556616
Drug-related deaths: standard definition2292332382317356336421455574545485584581527613
Extra deaths counted in the consistent series3176139109191625272223293
of which:
Mephedrone4 present000000000030000
Phenazepam5 present000000000001100
Tramadol6 present05212899161419171217273
Zopiclone6 present124111042679710
None of the above, but one or more other substances which are now controlled were present7000000000100110